MHRA has launched a consultation to gain a greater understanding of the potential application of AQbD in pharmacopoeial standards and the future of medicines standards.
Peter Crowley
Advertisement
Peter Crowley is principal pharmacopoeial scientist at the British Pharmacopoeia.
Articles by Peter Crowley
Advertisement
Latest Updated Articles
AQbD, the Evolution of Pharmacopoeial Standards?Published: July 17th 2019 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
AAPS PharmSci 360 2025: Instrumentation Innovation for Bioanalysis
2
Using A Streamlined Workflow to Identify Particulates in Biologic Drugs
3
Using AI and Molecular Dynamics to Overcome the Poor Solubility Challenge
4
From Lab to Patient: The Critical Role of Supply Chain & Distribution in the Life Sciences
5
